Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

Cited by (999)

Items 801–900 of 999

1. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial
   Lama Ghazi, Jason V. Baker, Shweta Sharma, Mamta K. Jain, Adrian Palfreeman, Coca Necsoi, Daniel D. Murray, James D. Neaton, Paul E. Drawz · 2019 · American Journal of Hypertension
2. Stroke in central nervous system infections
   Francisco Javier Carod-Artal · 2008 · Annals of Indian Academy of Neurology
3. Beyond post-marketing research and MedWatch: Long-term studies of drug risks
   David B. Resnik · 2007 · Drug Design Development and Therapy
4. Management of Persons Infected with Human Immunodeficiency Virus Requiring Admission to the Intensive Care Unit
   Darrell H. S. Tan, Sharon Lynn Walmsley · 2013 · Critical Care Clinics
5. Switching Antiretroviral Therapy to Minimize Metabolic Complications
   Jordan E. Lake, Judith S. Currier · 2010 · HIV Therapy
6. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients
   Marianne Harris · 2008 · Expert Opinion on Drug Safety
7. Clinical Factors Associated with Carotid Plaque and Intima-Medial Thickness in HIV-Infected Patients
   Su Jin Jeong, Hye Won Kim, Nam Su Ku, Sang Hoon Han, Chang Oh Kim, Jun Yong Choi, Young Goo Song, June Myung Kim · 2013 · Yonsei Medical Journal
8. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update
   Hugo Ribeiro Zanetti, Leonardo Roever, Alexandre Gonçalves, Elmiro Santos Resende · 2018 · Current Atherosclerosis Reports
9. Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir
   Magda Opsomer, Dessislava I. Dimitrova, J. Verspeelt, Amy Purrington, Abdul Mehbob, Scott Chavers, Helen Pai, Simon Vanveggel, Donghan Luo, Kimberley C. Brown et al. · 2018 · Drugs in R&D
10. Brief Report: Progression of Atherosclerosis in HIV-Infected Individuals—Prospective Data From an Asian Cohort
    Grace Chung-Yan Lui, Ronald C.W., Ping Chook, Chun Kwok Wong, Claudia H.T. Tam, Michael H.M. Chan, Shui Shan Lee, Rity Y. K. Wong, Catherine S. K. Cheung, Kin‐Wing Choi et al. · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes
11. Valvular manifestations of human immunodeficiency virus infection – results from the prospective, multicenter HIV-HEART study
    Nico Reinsch, Stefan Eßer, Götz Gelbrich, Norbert Hermann Brockmeyer, Anja Potthoff, Dirk Schadendorf, Raimund Erbel, Till Neumann · 2013 · Journal of Cardiovascular Medicine
12. Significant publications on infectious diseases pharmacotherapy in 2008
    Kristi M. Kuper, Elizabeth B. Hirsch, Vincent H. Tam · 2009 · American Journal of Health-System Pharmacy
13. Risk of myocardial infarction and nucleoside analogues
    James H. Stein, Judith S. Currier · 2008 · The Lancet
14. Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis
    Carl J. Fichtenbaum, Carlos Malvestutto, Maya Watanabe, Emma Davies Smith, Heather Jane Ribaudo, Sara McCallum, Kathleen V. Fitch, Judith S. Currier, Marissa R Diggs, Sarah M Chu et al. · 2025 · The Lancet HIV
15. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV
    Mario Cruciani, Carlo Mengoli, Giovanni Serpelloni, Saverio Giuseppe Parisi, Marina Malena, Oliviero Bosco · 2013 · Cochrane Database of Systematic Reviews
16. Growing Old with HIV
    Diixa Patel, Lawrence R. Crane · 2010 · Current Infectious Disease Reports
17. Effect of Highly Active Antiretroviral Therapy on Homocysteine Plasma Concentrations in HIV-1–Infected Patients
    Érika Coria-Ramírez, Leopoldo Nieto‐Cisneros, Sandra Treviño‐Pérez, Isabel Ibarra‐González, Jesús Casillas-Rodríguez, Abraham Majluf‐Cruz · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
18. Complications of Treatment in Youth with HIV
    Allison Ross Eckard, Sandra L. Fowler, Julia C. Haston, Terry C. Dixon · 2016 · Current HIV/AIDS Reports
19. Are we successfully managing cardiovascular disease in people living with HIV?
    Camilla Ingrid Hatleberg, Jens Dilling Lundgren, Lene Ryom · 2017 · Current Opinion in HIV and AIDS
20. Assessment of arterial elasticity among HIV ‐positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START ) trial
    JV Baker, Nicole Wyman Engen, Kathy Huppler Hullsiek, Christoph Stephan, Mamta K. Jain, Paula Munderi, Sarah Lilian Pett, Daniel A. Duprez, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group · 2015 · HIV Medicine
21. Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice.
    Enrico Cerrato, Fabrizio D’Ascenzo, Giuseppe Biondi‐Zoccai, Pierluigi Omedè, Claudio Moretti, Stefania Cicalini, Gurumurthy Parthasarathi, Imad Sheiban, Fiorenzo Gaïta · 2012 · Europe PMC (PubMed Central)
22. Cardiac Emergencies in Patients with HIV
    Rakesh Mishra · 2010 · Emergency Medicine Clinics of North America
23. Prevalence of Hyperapolipoprotein B and Associations with Other Cardiovascular Risk Factors Among Human Immunodeficiency Virus–Infected Patients in Pernambuco, Brazil
    Érico Higino de Carvalho, Demócrito de Barros Miranda-Filho, Ricardo Arraes de Alencar Ximenes, Maria de Fátima Pessoa Militão de Albuquerque, Heloísa Ramos Lacerda, Thais Gelenske, Zoraya de Medeiros Barros, Ulísses Ramos Montarroyos, Francisco Alfredo Farias Bandeira · 2010 · Metabolic Syndrome and Related Disorders
24. The maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart
    Kathleen M. S. E. Reyskens, M. Faadiel Essop · 2013 · International Journal of Cardiology
25. HIV and aging
    Lisa M Chirch, Mohamed Hasham, George A. Kuchel · 2014 · Current Opinion in HIV and AIDS
26. Emerging need to use phytopharmaceuticals in the treatment of HIV
    L. Chaitra Narayan, V. Ravishankar, Supinya Tewtrakul · 2013 · Journal of Pharmacy Research
27. Lipid Management in Human Immunodeficiency Virus
    Merle L. Myerson · 2016 · Endocrinology and Metabolism Clinics of North America
28. Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders
    Cindy J. Bednasz, Amneris Esther Luque, Barry S. Zingman, Margaret A. Fischl, Barbara Gripshover, Charles S. Venuto, Jie Gu, Zekun Feng, Robin DiFrancesco, Gene D. Morse et al. · 2016 · Current Vascular Pharmacology
29. Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease
    Chiara Bernelli, Gian Battista Danzi, Enrico Cerrato, Simona Pierini, M Ornaghi, Luca Botta, Francesco Gentile, Guglielmo Marco Migliorino, Nicola Squillace · 2019 · Canadian Journal of Cardiology
30. Low free testosterone in HIV ‐infected men is not associated with subclinical cardiovascular disease
    Anne Kress Monroe, Adrian Sandra Dobs, Xiaoqiang Xu, FJ Palella, Lawrence Kingsley, Wendy S. Post, MD Witt, Todd Tarquin Brown · 2012 · HIV Medicine
31. Psychiatric and neurophysiological predictors of obesity in HIV/AIDS
    Lance O. Bauer · 2008 · Psychophysiology
32. Antiretroviral Therapy With Heart
    Paul Anthony Randell, Graeme J Moyle · 2009 · American Journal of Therapeutics
33. Hospitalization risk following initiation of highly active antiretroviral therapy
    SA Berry, Yukari C Manabe, Richard D Moore, KA Gebo · 2009 · HIV Medicine
34. Lipoprotein(a) in patients initiating antiretroviral therapy
    Stefan Mauss, F Berger, Guenther Schmutz, J Henke, W O Richter · 2008 · HIV Medicine
35. Darunavir and Cardiovascular Risk: Evaluating the Data to Inform Clinical Care
    Virginia A. Triant, Mark Jacob Siedner · 2019 · The Journal of Infectious Diseases
36. Abacavir exposure and cardiovascular risk factors in HIV-positive patients with coronary heart disease: a retrospective case–control study
    Janine M. Trevillyan, Allen C. Cheng, Jennifer Hoy · 2012 · Sexual Health
37. A Prospective Study of Body Fat Redistribution, Lipid, and Glucose Parameters in HIV-Infected Patients Initiating Combination Antiretroviral Therapy
    Sharon Lynn Walmsley, Angela M. Cheung, George I Fantus, Kevin A Gough, Fiona Smaill, AK Azad, Christina C. Diong, Janet Raboud · 2008 · HIV Clinical Trials
38. Seek and treat: HIV update 2011
    Alan J. Taege · 2011 · Cleveland Clinic Journal of Medicine
39. Inflammation et VIH
    François Bricaire, Marc‐Antoine Valantin · 2011 · Bulletin de l Académie Nationale de Médecine
40. Screening and risk assessment for coronary artery disease in HIV infection: an unmet need
    James Nadel, C. Holloway · 2016 · HIV Medicine
41. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study
    Qi Wang, Haibo Ding, Junjie Xu, Wenqing Geng, Jing Liu, Xiaolin Guo, Jing Kang, Xiaolin Li, Yongjun Jiang, Hong Shang · 2016 · Lipids in Health and Disease
42. An Open-Label, Randomized Study of the Impact on Insulin Sensitivity, Lipid Profile and Vascular Inflammation by Treatment with Lopinavir/Ritonavir or Raltegravir in HIV-Negative Male Volunteers
    Paul Anthony Randell, Akil Jackson, Ana Milinkovic, Marta Boffito, Graeme J Moyle · 2016 · Antiviral Therapy
43. Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era
    Tianyu He, Elizabeth Falwell, Egidio Brocca‐Cofano, Ivona Pandrea · 2017 · Current Opinion in Virology
44. Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study
    Andrea Giacomelli, Federico Conti, Laura Pezzati, Letizia M Oreni, Anna Lisa Ridolfo, Valentina Morena, Cecilia Bonazzetti, Gabriele Pagani, Tiziana Formenti, Massimo Galli et al. · 2021 · BMC Infectious Diseases
45. Validation of an algorithm to identify antiretroviral‐naïve status at time of entry into a large, observational cohort of HIV‐infected patients
    Neel R. Gandhi, Janet P. Tate, Maria C. Rodriguez‐Barradas, David Rimland, Matthew Bidwell Goetz, Cynthia L. Gibert, Sheldon T. Brown, Kristin M. Mattocks, Amy C. Justice · 2013 · Pharmacoepidemiology and Drug Safety
46. Effect of Abacavir on Acute Changes in Biomarkers Associated with Cardiovascular Dysfunction
    Pragna Patel, Timothy J. Bush, Turner Overton, Jason V. Baker, John Hammer, Erna Milunka Kojic, Lois J. Conley, Keith Henry, John T. Brooks, the SUN Study Investigators · 2011 · Antiviral Therapy
47. Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy
    Su Jin Jeong, Chang Oh Kim, Young Goo Song, Ji Hyeon Baek, Sun Bean Kim, Sung Joon Jin, Nam Su Ku, Sang Hoon Han, Jun Yong Choi, Hyun Chul Lee et al. · 2011 · Atherosclerosis
48. Prevalence of calcified carotid artery atheromas in panoramic radiographs of HIV-positive patients undergoing antiretroviral treatment: a retrospective study
    Newton Guerreiro da Silva Júnior, Erick Nelo Pedreira, Fabrício Mesquita Tuji, Luiza Verônica Warmling, Karem López Ortega · 2013 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
49. Lipoprotein particle profiles by nuclear magnetic resonance spectroscopy in medically underserved HIV-infected persons
    Barbara A. Swanson, Beverly E. Sha, Joyce K. Keithley, Louis Fogg, Judith L. Nerad, Richard M. Novak, Oluwatoyin M Adeyemi · 2009 · Journal of clinical lipidology
50. Current advances in pharmacovigilance in the USA and Europe
    Kendall A. Marcus, Alfred F. Sorbello, Melissa M. Truffa, Julie Williams, June M. Raine, William G. Powderly · 2012 · Current Opinion in HIV and AIDS
51. Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events
    Herman G. Sprenger, Wouter F.W. Bierman, Melanie I. Martes, Reindert Graaff, Tjip S. van der Werf, Andries Jan Smit · 2016 · AIDS
52. Efficacy and safety of atazanavir/ritonavir-based antiretroviral therapy for HIV-1 infected subjects: a systematic review and meta-analysis
    Amr Menshawy, Ammar Ismail, Abdelrahman Ibrahim Abushouk, Hussien Ahmed, Esraa Menshawy, Ahmed Elmaraezy, Mohamed Gadelkarim, Mohamed Abdel-Maboud, Attia Attia, Ahmed Negida · 2017 · Archives of Virology
53. Cardiac Surgery in HIV Patients: State of the Art
    Bobby Yanagawa, Subodh Verma, Girish Dwivedi, Marc Ruel · 2018 · Canadian Journal of Cardiology
54. Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa
    Paul K. Drain, Ting Hong, Anjum Hajat, Meighan L. Krows, Sabina Govere, Hilary Thulare, Mahomed Yunus Suleman Moosa, Ingrid Valerie Bassett, Connie Celum · 2019 · PLoS ONE
55. Internal medicine/primary care reminder: What are the standards of care for HIV-positive patients aged 50 years and older?
    Keith Henry · 2009 · Current HIV/AIDS Reports
56. Increased carotid intima media thickness is associated with depletion of circulating myeloid dendritic cells in HIV-infected patients on suppressive antiretroviral treatment
    Miriam Lichtner, Maria Rosaria Cuomo, Raffaella Rossi, Stefano Strano, Anna Paola Massetti, Claudio Maria Mastroianni, Vincenzo Vullo · 2008 · Atherosclerosis
57. Trends in non-AIDS-related causes of death among adults with HIV/AIDS, Brazil, 1999 to 2010
    Erika Fazito, Ana Maria Nogales Vasconcelos, Maurício Gomes Pereira, Dilermando Fazito de Rezende · 2013 · Cadernos de Saúde Pública
58. Elevated NT-Pro-Brain Natriuretic Peptide Level Is Independently Associated with All-Cause Mortality in HIV-Infected Women in the Early and Recent HAART Eras in the Women’s Interagency HIV Study Cohort
    Matthew R. Gingo, Yingze Zhang, Kidane B. Ghebrehawariat, Jong‐Hyeon Jeong, Yanxia Chu, Quanwei Yang, Lorrie A. Lucht, David B. Hanna, Jason Lazar, Mark T. Gladwin et al. · 2015 · PLoS ONE
59. Protease inhibitor treatment effect on aortic stiffness in normotensive patients with human immunodeficiency virus infection
    Marilucy Lopez‐Sublet, P. Honoré, Michèle Bentata, Costas Bratis, François Rouges, Alain Krivitzky, Robin Dhôte, Jean‐Jacques Mourad · 2012 · Journal des Maladies Vasculaires
60. Age at menopause of HIV-infected women: A review
    Délio Marques Conde, Aarão Mendes Pinto-Neto, Lúcia Costa‐Paiva · 2008 · Gynecological Endocrinology
61. Fenofibrate in the treatment of dyslipidemia associated with HIV infection
    Divya Samineni, Carl J. Fichtenbaum · 2010 · Expert Opinion on Drug Metabolism & Toxicology
62. Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy
    Allison M. Martin, Sean Emery · 2009 · Expert Review of Clinical Pharmacology
63. Abacavir, Didanosine and Tenofovir do not Induce Inflammatory, Apoptotic or Oxidative Stress Genes in Coronary Endothelial Cells
    Chul Kim, Samir Kumar Gupta, Linden Ann Green, Brian M Taylor, Maja Deuter‐Reinhard, Zeruesenay Desta, Matthias A. Clauss · 2011 · Antiviral Therapy
64. The use of HIV-1 integrase inhibitors in antiretroviral naive patients
    Jeffrey L. Lennox · 2012 · Current Opinion in HIV and AIDS
65. Prevention of atherosclerosis in patients living with HIV
    Ferruccio De Lorenzo · 2009 · Vascular Health and Risk Management
66. Earlier initiation of antiretroviral therapy in treatment-na??ve patients: implications of results of treatment interruption trials
    James D. Neaton, Birgit Grund · 2008 · Current Opinion in HIV and AIDS
67. The safety of antiretroviral drugs
    Christopher N. Tymchuk, Judith S. Currier · 2008 · Expert Opinion on Drug Safety
68. Cardiac Risk: Not So Simple
    Judith A. Aberg, Heather Jane Ribaudo · 2009 · The Journal of Infectious Diseases
69. Primary Care of the Human Immunodeficiency Virus Patient
    Fred R. Buckhold · 2015 · Medical Clinics of North America
70. Dyslipidemia and statin use in people with HIV-1 infection: beyond the lipid-lowering effect
    Gianluca Gazzaniga, Marco Ridolfi, Alessandro Lazzaro, Tommaso Brogi, Pasquale Pignatelli, Daniele Pastori, Ivano Mezzaroma · 2025 · Nutrition Metabolism and Cardiovascular Diseases
71. Plasma Homocysteine Is Not Associated With HIV Serostatus or Antiretroviral Therapy in Women
    Farbod Raiszadeh, Donald R. Hoover, Irene Jeong-Ah Lee, Qiuhu Shi, Kathryn Anastos, Wei Gao, Robert C. Kaplan, Marshall Jay Glesby · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
72. Effects of ezetimibe on cholesterol metabolism in HIV-infected patients with protease inhibitor-associated dyslipidemia: a single-arm intervention trial
    Pere Leyes, Estebán Martínez, María Larrousse, Montserrat Cofán, Joan Trabal, Ana Pérez-Heras, María Forga, Emilio Ros · 2014 · BMC Infectious Diseases
73. Italian consensus statement on paediatric HIV infection
    Carlo Giaquinto, Martina Penazzato, Raffaella Rosso, Stefania Bernardi, Osvalda Rampon, Paola Nasta, Adriana Ammassari, Andrea Antinori, Raffaele Badolato, Guido Castelli Gattinara et al. · 2010 · Infection
74. State Variation in AIDS Drug Assistance Program Prescription Drug Coverage for Modifiable Cardiovascular Risk Factors
    Oni J. Blackstock, Karen Wang, David A. Fiellin · 2011 · Journal of General Internal Medicine
75. Extrinsic and Intrinsic Responses in the Development and Progression of Atherosclerosis
    Mariya Kuk, Natalie C. Ward, Girish Dwivedi · 2021 · Heart Lung and Circulation
76. Effects of a smartphone app‐based diet and physical activity program for men living with HIV who have dyslipidemia: A pilot randomized controlled trial
    Maki Aomori, Chiharu Matsumoto, Sanae Takebayashi, Nao Matsuyama, Yukiko Uto, Miho Tanaka, Sei Samukawa, Hideaki Kato, Hideaki Nakajima, Hitomi Maeda · 2023 · Japan Journal of Nursing Science
77. Management of bleeding disorders in the elderly
    Rebecca Kruse‐Jarres, Doris V. K. Quon, W. Schramm, Gerry Dolan · 2012 · Haemophilia
78. Patologia cardiovascular associada ao vírus da imunodeficiência humana
    Luísa Amado Costa, Ana G. Almeida · 2015 · Revista Portuguesa de Cardiologia
79. Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Metabolic Changes in HIV-1-Infected Africans: A Prospective Study
    Carla M T Fourie, Johannes Marthinus van Rooyen, Annamarie Kruger, Michael Hecht Olsen, Jesper Eugen‐Olsen, Rudolph Schutte, Aletta Elisabeth Schutte · 2011 · Inflammation
80. Devolving of statin prescribing to general practitioners for HIV-infected patients receiving antiretroviral therapy
    Paul D. Benn, Robert F. Miller, L Evans, Jane Minton, Simon Edwards · 2009 · International Journal of STD & AIDS
81. Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy
    Patrizia Carrieri, Camélia Protopopescu, Vincent Le Moing, Philippe Reboud, François Raffi, Sophie Mahy, Perrine Roux, Lise Cuzin, Bruno Spire, Catherine Leport et al. · 2012 · BMJ Open
82. Vascular stiffness and aging in HIV
    William Chan, Anthony Michael Dart · 2011 · Sexual Health
83. Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial
    Phanthaboon Wangpatharawanit, Somnuek Sungkanuparph M. D · 2016 · Clinical Infectious Diseases
84. Abacavir use and risk of recurrent myocardial infarction: the D: A: D study
    Caroline Anne Sabin, Lene Ryom, Antonella d’Arminio Monforte, Camilla Ingrid Hatleberg, Christian Pradier, Wafaa M. El-Sadr, Ole Kirk, Rainer K. Weber, Andrew N. Phillips, Amanda Mocroft et al. · 2017 · Zurich Open Repository and Archive (University of Zurich)
85. Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adults
    Martina Properzi, Paola Magro, Francesco Castelli, Eugenia Quirós-Roldán · 2018 · Expert Review of Anti-infective Therapy
86. Association of Low Vitamin D with Complications of HIV and AIDS: A literature Review
    Evelyn Chokuda, Chris Reynolds, Satyajit Das · 2018 · Infectious Disorders - Drug Targets
87. Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
    Martina Spaziante, Gloria Taliani, Giulia Carla Marchetti, Alessandro Tavelli, Miriam Lichtner, Antonella Cingolani, Stefania Cicalini, Elisa Biliotti, Enrico Girardi, Andrea Antinori et al. · 2021 · Viruses
88. Whole blood platelet aggregometry in HIV-infected patients on treatment with abacavir
    Rosario Palacios Muñoz, José Antonio González Correa, J. M. Torres Ruiz, Enrique Nuño, Manuel Márquez, José Pedro De La Cruz, Jesús Santos · 2012 · Open Journal of Internal Medicine
89. Clinical management of HIV-associated lipodystrophy
    Munir Pirmohamed · 2009 · Current Opinion in Lipidology
90. Antiretroviral compounds and cholesterol efflux from macrophages
    Nigora Mukhamedova, Honor May Rose, Huanhuan Cui, Angela Grant, Urbain Tchoua, Anthony Michael Dart, Michael Bukrinsky, Dmitri Sviridov · 2009 · Atherosclerosis
91. Safety of pharmacoenhancers for HIV therapy
    Nils von Hentig, Annette Haberl · 2012 · Expert Review of Clinical Pharmacology
92. Dyslipidemia, Atherosclerosis and Cardiovascular Disease: An Increasingly Important Triad in an Aging Population Living with HIV
    Jane A. O’Halloran, Claudette S. Satchell, Patrick W. G. Mallon · 2013 · Future Virology
93. Trends Related to Aging and Co-Occurring Disorders in HIV-Infected Drug Users
    Robert S. Klein · 2011 · Substance Use & Misuse
94. Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens
    Lisa C. Rosenblatt, Amanda M. Farr, Stephen S. Johnston, Ella T. Nkhoma · 2016 · Open Forum Infectious Diseases
95. Early Increases in Concentrations of Total, LDL, and HDL Cholesterol in HIV‐infected Children Following New Exposure to Antiretroviral Therapy
    Kevin A. Sztam, Hongyu Jiang, Andrea Jurgrau, Richard Joseph Deckelbaum, Marc D. Foca · 2011 · Journal of Pediatric Gastroenterology and Nutrition
96. Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?
    David Charles Boettiger, Caroline Anne Sabin, Andrew Edwin Grulich, Lene Ryom, Fabrice Bonnet, Peter Reiss, Antonella d’Arminio Monforte, Ole Kirk, Andrew N. Phillips, Mark Bower et al. · 2016 · AIDS
97. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
    Nicolai Lohse · 2016 · PubMed
98. Do nevirapine and efavirenz affect vitamin D homeostasis similarly?
    Tanya Welz, Kate Childs, Frank A. Post · 2011 · AIDS
99. Clinical Characteristics of HIV-Infected Patients Who Survive after the Diagnosis of HIV Infection for More Than 10 Years in a Resource-Limited Setting
    Sasisopin Kiertiburanakul, Pawinee Luengroongroj, Somnuek Sungkanuparph M. D · 2012 · Journal of the International Association of Physicians in AIDS Care
100. HIV Infection and Antiretroviral Treatment: A "Two-Hit" Model for Arterial Stiffness?
     Giuseppe Schillaci, Giacomo Pucci, Giuseppe Vittorio De Socio · 2009 · American Journal of Hypertension